BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33389397)

  • 1. Treating (low-risk) DCIS patients: What can we learn from real-world cancer registry evidence?
    Byng D; Retèl VP; Schaapveld M; Wesseling J; van Harten WH;
    Breast Cancer Res Treat; 2021 May; 187(1):187-196. PubMed ID: 33389397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women.
    Elshof LE; Schaapveld M; Schmidt MK; Rutgers EJ; van Leeuwen FE; Wesseling J
    Breast Cancer Res Treat; 2016 Oct; 159(3):553-63. PubMed ID: 27624164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast.
    van Seijen M; Lips EH; Fu L; Giardiello D; van Duijnhoven F; de Munck L; Elshof LE; Thompson A; Sawyer E; Ryser MD; Hwang ES; Schmidt MK; Elkhuizen PHM; ; Wesseling J; Schaapveld M
    Br J Cancer; 2021 Nov; 125(10):1443-1449. PubMed ID: 34408284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of contemporary treatment of DCIS on the risk of developing an ipsilateral invasive Breast cancer (iIBC) in the Dutch population.
    Alaeikhanehshir S; Schmitz RSJM; van den Belt-Dusebout AW; van Duijnhoven FH; Verschuur E; van Seijen M; Schaapveld M; Lips EH; Wesseling J;
    Breast Cancer Res Treat; 2024 Feb; 204(1):61-68. PubMed ID: 37964135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation.
    Punglia RS; Cronin AM; Uno H; Stout NK; Ozanne EM; Greenberg CC; Frank ES; Schrag D
    JAMA Oncol; 2017 Jan; 3(1):101-104. PubMed ID: 27442038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma
    Visser LL; Elshof LE; Schaapveld M; van de Vijver K; Groen EJ; Almekinders MM; Bierman C; van Leeuwen FE; Rutgers EJ; Schmidt MK; Lips EH; Wesseling J
    Clin Cancer Res; 2018 Aug; 24(15):3593-3601. PubMed ID: 29685879
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple foci of microinvasion is associated with an increased risk of invasive local recurrence in women with ductal carcinoma in situ treated with breast-conserving surgery.
    Rakovitch E; Sutradhar R; Lalani N; Nofech-Mozes S; Gu S; Goldberg M; Hanna W; Fong C; Paszat L
    Breast Cancer Res Treat; 2019 Nov; 178(1):169-176. PubMed ID: 31325071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study.
    Groen EJ; Hudecek J; Mulder L; van Seijen M; Almekinders MM; Alexov S; Kovács A; Ryska A; Varga Z; Andreu Navarro FJ; Bianchi S; Vreuls W; Balslev E; Boot MV; Kulka J; Chmielik E; Barbé E; de Rooij MJ; Vos W; Farkas A; Leeuwis-Fedorovich NE; Regitnig P; Westenend PJ; Kooreman LFS; Quinn C; Floris G; Cserni G; van Diest PJ; Lips EH; Schaapveld M; Wesseling J;
    Breast Cancer Res Treat; 2020 Oct; 183(3):759-770. PubMed ID: 32734520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
    Narod SA; Iqbal J; Giannakeas V; Sopik V; Sun P
    JAMA Oncol; 2015 Oct; 1(7):888-96. PubMed ID: 26291673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy.
    Giannakeas V; Sopik V; Narod SA
    JAMA Netw Open; 2018 Aug; 1(4):e181100. PubMed ID: 30646103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reoperation Rates in Ductal Carcinoma In Situ vs Invasive Breast Cancer After Wire-Guided Breast-Conserving Surgery.
    Langhans L; Jensen MB; Talman MM; Vejborg I; Kroman N; Tvedskov TF
    JAMA Surg; 2017 Apr; 152(4):378-384. PubMed ID: 28002557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis.
    Warren JL; Weaver DL; Bocklage T; Key CR; Platz CE; Cronin KA; Ballard-Barbash R; Willey SC; Harlan LC
    Cancer; 2005 Nov; 104(9):1840-8. PubMed ID: 16136599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study.
    Sagara Y; Freedman RA; Vaz-Luis I; Mallory MA; Wong SM; Aydogan F; DeSantis S; Barry WT; Golshan M
    J Clin Oncol; 2016 Apr; 34(11):1190-6. PubMed ID: 26834064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of a Diagnosis of Ductal Carcinoma In Situ With Death From Breast Cancer.
    Giannakeas V; Sopik V; Narod SA
    JAMA Netw Open; 2020 Sep; 3(9):e2017124. PubMed ID: 32936299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.
    Rakovitch E; Nofech-Mozes S; Hanna W; Baehner FL; Saskin R; Butler SM; Tuck A; Sengupta S; Elavathil L; Jani PA; Bonin M; Chang MC; Robertson SJ; Slodkowska E; Fong C; Anderson JM; Jamshidian F; Miller DP; Cherbavaz DB; Shak S; Paszat L
    Breast Cancer Res Treat; 2015 Jul; 152(2):389-98. PubMed ID: 26119102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis.
    Rakovitch E; Nofech-Mozes S; Narod SA; Hanna W; Thiruchelvam D; Saskin R; Taylor C; Tuck A; Sengupta S; Elavathil L; Jani PA; Done SJ; Miller N; Youngson B; Kong I; Paszat L
    Breast Cancer Res Treat; 2013 Apr; 138(2):581-90. PubMed ID: 23456231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of radiation therapy in older women with ductal carcinoma in situ.
    Smith BD; Haffty BG; Buchholz TA; Smith GL; Galusha DH; Bekelman JE; Gross CP
    J Natl Cancer Inst; 2006 Sep; 98(18):1302-10. PubMed ID: 16985249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situ.
    Liu Y; West R; Weber JD; Colditz GA
    Cancer; 2019 Sep; 125(18):3225-3233. PubMed ID: 31120565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.
    Rivera R; Banks A; Casillas-Lopez A; Rashtian A; Lewinsky B; Sheth P; Hovannesian-Larsen L; Brousseau D; Iyengar G; Holmes DR
    Breast J; 2016; 22(1):63-74. PubMed ID: 26534876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study.
    Schmitz RSJM; van den Belt-Dusebout AW; Clements K; Ren Y; Cresta C; Timbres J; Liu YH; Byng D; Lynch T; Menegaz BA; Collyar D; Hyslop T; Thomas S; Love JK; Schaapveld M; Bhattacharjee P; Ryser MD; Sawyer E; Hwang ES; Thompson A; Wesseling J; Lips EH; Schmidt MK;
    BMJ; 2023 Oct; 383():e076022. PubMed ID: 37903527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.